317 search results for “clinical thijs” in the Student website
-
Thijs KromhoutISSC
-
Thijs LemaireFaculteit der Rechtsgeleerdheid
-
Thijs LoggenISSC
-
Thijs SchepensUniversity Facility Services
-
Thijs BuurmanISSC
-
Thijs Aartsma -
Thijs Hartmann -
Thijs Hoogenboom -
Thijs Voskuilen -
Thijs BusschotsFaculteit der Rechtsgeleerdheid
-
Thijs Bosker -
Thijs de BackFaculty of Social and Behavioural Sciences
-
Thijs van VeenUniversity Facility Services
-
Thijs van den BergFaculty of Social and Behavioural Sciences
-
Thijs VosFaculty of Social and Behavioural Sciences
-
Thijs WittyFaculty of Humanities
-
Thijs PorckFaculty of Humanities
-
Thijs van Osch -
Thijs van Kolfschoten -
Thijs de BoerFaculteit Governance and Global Affairs
-
Thijs Jan van Schie
-
Thijs van BeekFaculteit der Rechtsgeleerdheid
-
Thijs van DooremalenFaculteit Governance and Global Affairs
-
Thijs Brocades ZaalbergFaculty of Humanities
-
Joes ten Thij -
Anne van GiezenFaculty of Social and Behavioural Sciences
-
Five questions for Thijs Bosker about Local Actions
Sustainability challenges don’t just call for environmental scientists – they require expertise from many academic fields. Thijs Bosker and Paul Behrens have made it easier for university lecturers to integrate sustainability into their courses. Their initiative, Local Actions, offers ready-made teaching…
-
Smart monitoring of test subjects is the future of clinical research
Knowing whether or not a treatment is working just by wearing your watch? Data scientist Ahnjili ZhuParris has identified a lot of opportunities for the use of machine learning in clinical research to monitor test subjects at home.
-
Manja KoendersFaculty of Social and Behavioural Sciences
-
Johanna Greeven
Faculty of Social and Behavioural Sciences
-
Leiden-developed drug candidate ready for final clinical trial phase
Bringing your drug candidates to patients is what many academic chemists dream about, but the road to this goal is long and bumpy. Now, Leiden small molecule nizubaglustat is ready for phase 3 clinical trials. This is thanks to a €132 million funding secured by the biotech spin-out Azafaros.
-
Cevdet Acarsoy -
Jannik Rousel -
Rianne de KleineFaculty of Social and Behavioural Sciences
-
Maartje SchoorlFaculty of Social and Behavioural Sciences
-
‘Never stop trying’: Barz sees his polymers enter clinical trials
A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in 2014 by chemist Matthias Barz from Leiden University, it offers a unique alternative to current options.
-
Eline DekeysterFaculty of Social and Behavioural Sciences
-
Chris VerhoevenFaculty of Social and Behavioural Sciences
-
Laura SteenbergenFaculty of Social and Behavioural Sciences
-
Catherijne Knibbe -
Veronica Janssen
Faculty of Social and Behavioural Sciences
-
Frank Baas -
Lifeng Han -
Elmer Maurits -
Friedo Dekker -
Jump for Joy – Fitness clinic
Arts and culture
-
Bernet ElzingaFaculty of Social and Behavioural Sciences
-
Frits Rosendaal -
Annelies OskamFaculty of Social and Behavioural Sciences
-
Nina KomrijFaculty of Social and Behavioural Sciences